Written by Ad OpsOverview
Ringo's Gift (CBD) is a celebrated CBD-forward cultivar renowned for its calm, clear-headed experience and exceptionally low intoxicating impact. Bred in Northern California and named for CBD pioneer Lawrence Ringo, it quickly became a flagship variety for wellness-oriented consumers and medical patients. Its acclaim rests on consistent high-CBD:low-THC chemotypes, typically delivering CBD in the low- to mid-teens as a percentage by dry weight while keeping THC around or below 1% in CBD-dominant cuts.
Compared to THC-heavy strains, Ringo's Gift emphasizes relaxation, focus, and bodily ease without pronounced euphoria or impairment. Multiple phenotypes exist, ranging from 1:1 CBD:THC to ultra-high-CBD 20:1 and above; however, dispensaries most often stock the CBD-dominant expressions. In April 2016, the strain earned broader recognition when industry coverage noted it among the Top 10 Strains of the month, aligning with a wave of interest in terpene-forward, effect-specific cannabis at retailers such as Harborside.
Beyond the consumer experience, Ringo's Gift is a workhorse in gardens thanks to its balanced vigor and manageable structure. Indoor flowering typically completes in 8–10 weeks, and outdoor harvests land from late September to mid-October in temperate climates. Growers prize it for repeatable chemotypes under stable conditions, while patients appreciate its consistent relief profile across batches.
The cultivar's organoleptic appeal is subtle and sophisticated, mixing pine and earth with citrus zest and a peppery finish. Terpene analyses frequently highlight beta-caryophyllene, myrcene, and alpha-pinene as leading contributors, supported by secondary notes of limonene and humulene. With total terpenes commonly in the 1.2–2.5% range, it delivers a nuanced bouquet that complements its gentle, functional effects.
History and Cultural Impact
Ringo's Gift is named for Lawrence Ringo, co-founder of Southern Humboldt Seed Collective (SoHum Seeds) and one of the earliest advocates for CBD-rich cannabis in the United States. In the late 2000s and early 2010s, Ringo focused on breeding high-CBD lines at a time when most of the market emphasized high-THC potency. His work helped catalyze a broader shift toward cannabinoid diversity and patient-centered breeding goals, culminating in cultivars like Harle-Tsu and Sour Tsunami.
The emergence of Ringo's Gift coincided with a growing medical cannabis movement and expanding patient registries across legal markets. As dispensaries grew more sophisticated in curation, CBD cultivars found prominent shelf space, aided by educational outreach about non-intoxicating cannabinoids. Harborside Health Center, an early leader in lab-tested cannabis, helped popularize CBD-forward strains by providing consistent analytics and patient guidance.
Media coverage and consumer rankings helped cement Ringo's Gift as a staple CBD variety. In April 2016, industry reporting tied to Marley Natural and Harborside highlighted Ringo's Gift as one of the Top 10 Strains of the month, illustrating how consumer interest was shifting toward terpene-defined experiences and therapeutic outcomes. This recognition amplified the strain’s visibility to both wellness consumers and traditional enthusiasts seeking daytime-friendly options.
Beyond retail attention, Ringo's Gift contributed to normalization of conversations around dosage, ratios, and minor cannabinoids. The cultivar frequently appeared in patient forums and caregiver networks as a dependable choice for anxiety, pain, and inflammation. Over time, it became a reference point for comparing CBD chemotypes and a breeding parent used to propagate high-CBD genetics in new projects.
Genetic Lineage and Breeding
Ringo's Gift is generally described as Harle-Tsu × ACDC, uniting two foundational CBD varieties. Harle-Tsu itself is a high-CBD hybrid associated with Harlequin and Sour Tsunami lines, historically linked to Lawrence Ringo’s work. ACDC is a CBD-dominant phenotype of Cannatonic, known for ratio expressions that can exceed 20:1 CBD:THC in some cuts.
Combining these parents increases the probability of CBD-dominant offspring due to the presence of recessive alleles that favor CBD synthesis over THC. In simple terms, both parents tend to carry genetic variants that prioritize CBDA production via the CBDA synthase pathway. While cannabis inheritance is complex and polygenic, this parental pairing statistically enriches for CBD-forward phenotypes compared to crosses with THC-leaning lines.
Breeders and clone providers report several stable phenotypes within Ringo's Gift, often categorized by their CBD:THC ratios. Common expressions include a high-CBD 15–20:1 phenotype, a moderate 10–15:1 phenotype, and an occasional balanced 1:1 phenotype. Cultivation practices and environmental variables can shift measured potency by several percentage points, but genetic predisposition strongly influences the ratio spectrum.
As a breeding parent, Ringo's Gift has been leveraged to introduce reliable CBD expression into new hybrids. When crossed with terpene-rich but THC-dominant cultivars, it can pull the ratio toward balance while diversifying aroma. When used with other CBD lines, the progeny often present high-CBD chemotypes with relatively minor THC variance, aiding product developers aiming for compliance and consistent consumer experiences.
Appearance
Ringo's Gift typically forms medium-density, spear-shaped flowers with a balanced calyx-to-leaf ratio. The buds exhibit a vivid lime to forest-green palette, often with golden pistils that darken to rust as maturity approaches. Under cooler nights, some phenotypes show faint lavender hues due to anthocyanin expression, especially in late-flower.
Trichome coverage is generous and glassy, with bulbous heads that appear bright rather than amber-heavy during peak ripeness. Despite low THC, resin production remains robust because trichome development is not exclusive to THC synthesis. Well-grown flowers show a sparkling frost that resists matting if handled carefully during drying and trimming.
Internodal spacing is moderate, producing a balanced, bushy structure that responds well to topping and low-stress training. Fan leaves present a hybrid morphology—neither overly broad nor thin—with healthy, turgid blades under optimized nutrition. Plants typically reach medium height indoors, though vigorous phenotypes may stretch 1.5× after flip.
Finished buds cure to a springy but firm texture if dried at 60–62% relative humidity, preventing terpene loss while avoiding overdry crumble. A proper, slow cure accentuates the citrus-pine bouquet and rounds off any grassy notes from chlorophyll. Hand-trimmed flowers better preserve the gland heads, enhancing mouthfeel and perceived potency.
Aroma and Flavor
Dry pulls from a freshly ground sample of Ringo's Gift yield pine needles, cracked pepper, and a sweet citrus top note. Many batches carry a subtle herbal tea quality, reminiscent of lemongrass and green tea, with a gentle earthiness beneath. The nose is clean and refreshing rather than sweet-heavy or diesel-forward.
On combustion or vaporization, expect a bright, piney inhale with soft citrus that fades into a peppery-woody exhale. A faint floral aspect appears in the mid-palate, similar to chamomile or orange blossom, depending on the cut. Consumers frequently describe the finish as crisp, with a dry, resinous aftertaste akin to juniper.
Terpene balance plays a central role in this profile. Beta-caryophyllene contributes the pepper-spice edge, while alpha-pinene supports the conifer and refreshing lift. Myrcene and limonene round out the earth-citrus core, leading to a flavor that feels both grounding and gently energizing.
Vaporization at 170–185°C (338–365°F) preserves the citrus-pinene top notes and yields the smoothest expression of the bouquet. Combustion increases the peppery, woody tones but can mute the zest if temperatures run too hot. Hash rosin or live resin from this cultivar often emphasizes pine and pepper over citrus, especially when extracted at lower temperatures.
Cannabinoid Profile and Ratios
Ringo's Gift is most widely known for high CBD content paired with minimal THC, though phenotypic variance is common. CBD-dominant cuts frequently test between 10–18% CBD by dry weight, with THC ranging from 0.3–1.0%. Balanced phenotypes around 1:1 can present 6–10% CBD and 6–10% THC, but these are less common in dispensary channels marketed as "Ringo's Gift (CBD)."
In raw flower, CBDA typically constitutes the majority of the measurable CBD fraction prior to decarboxylation. Labs often report that 70–90% of total CBD is present in its acidic form, depending on drying and storage conditions. Upon heating, CBDA converts to CBD with a decarboxylation efficiency typically estimated between 70–90% depending on temperature, time, and moisture content.
Minor cannabinoids in this cultivar may include CBC in the 0.1–0.6% range and CBG or CBGA typically between 0.2–1.0%. THCV is usually present only in trace amounts, rarely exceeding 0.2% in CBD-dominant phenotypes. Total cannabinoids commonly sum to 12–20% in high-CBD expressions, with extraction-ready material occasionally pushing higher.
Because chemotype can shift with environment, growers seeking the highest CBD:THC ratios should prioritize stable clone-only selections verified by third-party lab reports. Environmental stress, late harvests, and high-light intensity near finish can nudge THC marginally higher in some genotypes. For product formulators, blending batches to standardize a target ratio (for example, 20:1 CBD:THC) is a common practice to maintain label consistency.
Terpene Profile and Chemistry
Terpene analytics on Ringo's Gift commonly show total terpene content between 1.2% and 2.5% by dry weight, though ranges from 0.8% to 3.0% are reported. Beta-caryophyllene is frequently the dominant terpene at 0.2–0.6%, contributing a warm, peppery spice and potential CB2 receptor activity. Myrcene typically ranges from 0.3–0.8%, lending an earthy, herbal base and, in higher concentrations, mild sedative synergy for some users.
Alpha-pinene often appears at 0.1–0.4%, aligning with the pine needle aroma and reputed focus-enhancing effects noted anecdotally. Limonene is commonly 0.1–0.3%, bringing citrus brightness and an uplifting tenor to the profile. Humulene at 0.1–0.3% adds a woody, hop-like dryness that becomes more apparent after a slow cure.
Secondary and trace terpenes may include linalool (0.05–0.15%) and ocimene or terpinolene in very small amounts depending on phenotype. While linalool is rarely dominant in this cultivar, its lavender-like softness can subtly modulate the pepper-pine core. The overall terpene matrix creates an aroma that reads clean and botanical rather than sweet or fuel-heavy.
From a functional perspective, the terpene mix supports Ringo's Gift’s clear-headed, non-sedating reputation. Pinene and limonene can counterbalance myrcene's heaviness, yielding a calm but alert effect. Caryophyllene’s interaction with CB2 is often cited as a plausible mechanism underpinning perceived anti-inflammatory benefits, complementing CBD’s broad receptor and enzyme interactions.
Experiential Effects and Onset
Consumers consistently describe Ringo's Gift as calming, clear, and functional, with little to no intoxication from CBD-dominant cuts. The body feel is gentle and diffuse, often described as a light unwinding of muscle tension without couchlock. Mentally, it tends to reduce stress chatter and performance jitters while preserving focus and speech.
Inhaled, the onset typically begins within 2–5 minutes, with peak effects around 15–30 minutes and a 2–3 hour duration. Vaporization produces the cleanest, most terpene-forward experience, while low-temperature combustion still delivers fast relief. Edibles and tinctures have a slower onset, usually 30–60 minutes, with effects lasting 4–6 hours depending on dose and metabolism.
Many users report enhanced task engagement at low to moderate doses, especially for reading, creative brainstorming, or light physical activity. At higher doses, some may experience mild sedation driven by myrcene content and CBD’s anxiolytic properties. Balanced phenotypes with higher THC can introduce a gentle euphoria; consumers seeking minimal intoxication should confirm lab ratios before purchase.
Dosing varies by individual and product form. Beginners often start with 5–15 mg CBD per session for inhalation or 10–25 mg orally, adjusting as needed. For experienced users or specific use cases, daily totals of 50–100+ mg CBD are common, typically divided into two or three administrations to preserve steady-state effects.
Potential Medical Applications
While Ringo's Gift is not a medical treatment, its high-CBD, low-THC profile aligns with research on CBD’s potential benefits. CBD has demonstrated anticonvulsant properties, with randomized controlled trials in pediatric epilepsies showing clinically meaningful seizure reductions. In open-label and placebo-controlled studies on Dravet syndrome and Lennox–Gastaut syndrome, median reductions around 36–50% in seizure frequency have been reported with pharmaceutical-grade CBD.
Anxiety is another frequently cited area of CBD interest. A real-world clinical series published in 2019 observed significant improvements in anxiety scores for most participants after one month of daily CBD, though study designs vary and placebo effects can be substantial. Patients commonly report that Ringo's Gift supports situational anxiety relief without the fog or short-term memory disruption associated with THC-heavy strains.
For pain and inflammation, CBD’s multifaceted actions—modulation of TRPV1, adenosine signaling, and cytokine expression—may contribute to perceived relief. Beta-caryophyllene’s CB2 receptor affinity could further support anti-inflammatory effects in concert with CBD. Users with arthritis, repetitive strain, or post-exercise soreness often describe a reduction in baseline discomfort paired with improved mobility.
Sleep outcomes are mixed and dose-dependent. Lower doses of CBD can be alerting for some, while moderate evening doses may reduce sleep latency by quieting intrusive thoughts and muscle tension. Myrcene content in certain phenotypes can add a subtle sedative layer, which some patients leverage for nighttime comfort.
Gastrointestinal relaxation and reduced gut reactivity are anecdotally reported, likely tied to CBD’s influence on the enteric nervous system. Individuals with IBS-like symptoms sometimes cite Ringo's Gift as a gentle option that reduces cramping without appetite suppression. As always, effects are individual, and medical evaluation should guide strategies for chronic conditions.
It bears emphasis that plant chemovars vary, and not all Ringo's Gift batches will fit the same therapeutic niche. Lab-verified ratios and terpene data can help clinicians and patients match products to goals, such as a 20:1 CBD:THC flower for daytime anxiety or a balanced 1:1 for neuropathic pain. Tracking dose, timing, and outcomes in a symptom journal enhances the likelihood of finding a consistent benefit.
Comprehensive Cultivation Guide
Ringo's Gift is a cooperative cultivar for both first-time and advanced growers, with moderate vigor and a forgiving nutrient profile. Indoors, expect an 8–10 week flowering window under 12/12 photoperiod, finishing faster in dialed-in environments. Outdoors in the Northern Hemisphere, plan for late September to mid-October harvests depending on latitude and microclimate.
Start with clean genetics—verified clone or stabilized seed—from reputable sources to ensure a CBD-dominant chemotype. Clones reduce variability and shorten the time to harvest; seeds allow phenotype hunting for preferred terpene expressions and bud structure. Regardless of starting material, early testing (week 4–5 of flower) with quick-turn analytics can confirm trajectory towar
